Physician profile
Michael Brunner
NPI 1215166319
$1,669.90
in general payments reported to CMS, 2019-2025
21 companies · $47.82 in 2025
The $47.82 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,157 · 2020: $42.79 · 2021: $300 · 2023: $122 · 2025: $47.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $339.58 | 2019-2021 | |
| Amgen INC. | $254.86 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $238.42 | 2019 | |
| Lilly USA, LLC | $183.04 | 2019-2023 | Mounjaro |
| Medtronic Vascular, INC. | $139.76 | 2019 | |
| Astellas Pharma US INC | $92.40 | 2019 | |
| Janssen Pharmaceuticals, INC | $58.37 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $42.79 | 2020 | |
| Novartis Pharmaceuticals Corporation | $39.33 | 2019 | |
| Novo Nordisk INC | $39.21 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.76 | 2019 | |
| Pfizer INC. | $36.98 | 2019 | |
| Genentech USA, INC. | $24.97 | 2025 | Venclexta |
| Merck Sharp & Dohme LLC | $23.10 | 2019 | |
| Edwards Lifesciences Corporation | $22.85 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.41 | 2019 | |
| Amarin Pharma, INC. | $17.69 | 2019 | |
| Abbvie INC. | $15.81 | 2019 | |
| Glaxosmithkline, LLC. | $15.39 | 2019 | |
| Allergan, INC. | $13.68 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brunner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.